MLH1 and cancer: We observed that AND-1-binding by these cancer-related FANCJ mutants is severely compromised, while the DNA helicase activity and the interaction with other known protein binding partners (BRCA1, BLM and MLH1; see Fig. EV4A) is not altered, as compared to the wild-type protein.